What is common between functional dyspepsia and bacterial overgrowth syndrome
PDF (Русский)
DOCX

Keywords

functional dyspepsia, proton pump inhibitors, bacterial overgrowth syndrome, pathogenetic link, probiotics

How to Cite

Plotnikova, E. Y., Zakharova, Y. V., & Gracheva, T. Y. (2018). What is common between functional dyspepsia and bacterial overgrowth syndrome. Herald of Pancreatic Club, 40(3), 62-70. https://doi.org/10.33149/vkp.2018.03.09

Abstract views: 67
PDF Downloads: 63 PDF Downloads: 32

Abstract

The article presents the results of a review of various syndromes that occur in the pathology of the digestive system. Functional dyspepsia and the principles of its treatment are considered in detail. Proton pump inhibitors are one of the main groups of drugs used to treat functional dyspepsia. A serious complication of prolonged use of proton pump inhibitors is the syndrome of small intestinal bacterial overgrowth. The main principles of treatment of this complication are antibacterial therapy and probiotics. Enterobseptic Novobismol® and modern probiotic Maxilak® can be drugs of choice in this situation.

https://doi.org/10.33149/vkp.2018.03.09
PDF (Русский)
DOCX

References

1. Маев И. В. Терапевтическая тактика при синдроме избыточного бактериального роста в тонкой кишке / И. В. Маев, А. А. Самсонов // Consilium-Medicum. – 2007. – Vol. 7. – P. 45–56.
2. Минушкин О. Н. Сложные вопросы терапии ингибиторами протонной помпы / О. Н. Минушкин // Лечащий врач. – 2007. – №6. – P. 12–16.
3. Некоторые аспекты диагностики и лечения избыточной бактериальной контаминации тонкой кишки в клинической практике / Е. Ю. Плотникова, М. В. Борщ, М. В. Краснова, Е. Н. Баранова // Лечащий врач. – 2013. – №2. – С. 52–56.
4. Плотникова Е. Ю. Препараты висмуты в практике врача / Е. Ю. Плотникова, А. С. Сухих // Лечащий врач. – 2016. – №2. – С. 60-66
5. Шендеров Б. А. Медицинская микробная экология и функциональное питание / Б. А. Шендеров. – Т. 3. Пробиотики и функциональное питание. – М., Изд-во Грантъ, 2001. – 287 с.
6. 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases : the Rome Consensus Conference / A. Gasbarrini, G. R. Corazza, G. Gasbarrini, M. Montalto // Aliment. Pharmacol. Ther. – 2009. – Vol. 29, No 1. – P. 1–49.
7. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome / M. Lemann, J. P. Dederding, B. Flourie [et al.] // Digestive Diseases and Sciences. – 1991. – Vol. 36, No 9. – P. 1249–1254.
8. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety : a H215O-PET study / L. Van Oudenhove, J. Vandenberghe, P. Dupont [et al.] // American Journal of Gastroenterology. – 2010. – Vol. 105, No 4. – P. 913–924.
9. Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity / F. Zeng, W. Qin, F. Liang [et al.] // Gastroenterology. – 2011. – Vol. 141, No 2. – P. 499–506.
10. Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome / M. Di Stefano, E. Miceli, A. Missanelli [et al.] // Aliment. Pharmacol. Ther. – 2005. – Vol. 21. – P. 985–992.
11. Acid infusion enhances duodenal mechanosensitivity in healthy subjects / M. Simrén, R. Vos, J. Janssens, J. Tack // American Journal of Physiology. – 2003. – Vol. 285, No 2. – P. G309–G315.
12. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III Criteria) in a Swedish population-based study / P. Aro, N. J. Talley, J. Ronkainen [et al.] // Gastroenterology. – 2009. – Vol. 137, No 1. – P. 94–100.
13. Bacterial overgrowth during treatment with omeprazole compared with cimetidine : a prospective randomised double blind study / J. Thorens, F. Froehlichn, W. Schwizer [et al.] // Gut. – 1996. – Vol. 39. – P. 54–59.
14. Bierer D. W. Bismuth subsalicylate: history, chemistry, and safety / D. W. Bierer // Rev. Infect. Dis. – 1990. – Vol. 12 – Р. S3–S8.
15. Bishop W. P. Breath hydrogen testing for small bowel bacterial overgrowth – a lot of hot air? / W. P. Bishop // J. Pediatr. Gastroenterol. Nutr. – 1997. – Vol. 25. – P. 245–246.
16. The brain–gut pathway in functional gastrointestinal disorders is bidirectional : a 12-year prospective population-based study / N. A. Koloski, M. Jones, J. Kalantar [et al.] // Gut. – 2012. – Vol. 61, No 9. – P. 1284–1290.
17. Cavicchi M. Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors / M. Cavicchi, L. Gibbs, B. J. Whittle // Gut. – 2000. – Vol. 47. – Р. 771–778.
18. Collen M. J. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis / M. J. Collen, M. J. Loebenberg // Digestive Diseases and Sciences. – 1989. – Vol. 34, No 2. – P. 246–250.
19. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia / E. J. Castillo, M. Camilleri, G. R. Locke [et al.] // Clinical Gastroenterology and Hepatology. – 2004. – Vol. 2, No 11. – P. 985–996.
20. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease / T. Shindo, S. Futagami, T. Hiratsuka [et al.] // Digestion. – 2009. – Vol. 79, No 2. – P. 65–72.
21. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease / D. Figueroa-Quintanilla, E. Salazar-Lindo, R. B. Sack [et al.] // N. Engl. J. Med. – 1993. – Vol. 328. – Р. 1653–1658.
22. Current understanding of pathogenesis of functional dyspepsia / H. Miwa, J. Watari, H. Fukui [et al.] // Journal of Gastroenterology and Hepatology. – 2011. – Vol. 26, No 3. – P. 53–60.
23. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or omatisation? / L. Van Oudenhove, J. Vandenberghe, B. Geeraerts [et al.] // Gut. – 2008. – Vol. 57, No 12. – P. 1666–1673.
24. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole / M. Fried, H. Siegrist, R. Frei [et al.] // Gut. – 1994. – Vol. 35. – P. 23–26.
25. Dysfunctional gastric emptying with down-regulation of muscle-specific MicroRNAs in helicobacter pylori-infected mice / Y. Saito, H. Suzuki, H. Tsugawa [et al.] // Gastroenterology. – 2011. – Vol. 140, No 1. – P. 189–198.
26. Ericsson C. D. Antisecretory and antiinflammatory properties of bismuth subsalicylate / Ericsson C. D., Tannenbaum C., Charles T. T. // Rev. Infect. Dis. – 1990. – Vol. 12. – Р. S16–S20.
27. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease / E. Savarino, D. Pohl, P. Zentilin [et al.] // Gut. – 2009. – Vol. 58, No 9. – P. 1185–1191.
28. Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia / K. Ogiso, A. Asakawa, H. Amitani, A. Inui // Journal of Gastroenterology and Hepatology. – 2011. – Vol. 26, No 3. – P. 67–72.
29. Gorbach S. L. Probiotics andgastrointestinal health / S. L. Gorbach // Am. J. Gastroenterol. – 2000. – Vol. 1. – P. 2–4.
30. Gryboski J. D. Effect of bismuth subsalicylate on chronic diarrhea in childhood: a preliminary report / J. D. Gryboski, S. Kocoshis // Rev Infect Dis. – 1990. – Vol. 12. – Р. S36–S40.
31. Haboubi N. Y. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotics treatment / N. Y. Haboubi, G. S. Lee, R. D. Montgomery // Age Ageing. – 1991. – Vol. 20. – P. 29–32.
32. Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome / F. de Giorgi, G. Sarnelli, C. Cirillo [et al.] // Neurogastroenterology and Motility. – 2012. – Vol. 25, No 1. – P. 31–38.
33. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans / J. Tack, D. Broekaert, B. Coulie [et al.] // Aliment. Pharmacol. Ther. – 2003. – Vol. 17. – P. 603–608.
34. Knowles C. H., Aziz Q. Visceral hypersensitivity in nonerosive reflux disease / C. H. Knowles, Q. Aziz // Gut. – 2008. – Vol. 57, No 5. – P. 674–683.
35. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors / C. Rousseaux, X. Thuru, A. Gelot [et al.] // Nat. Med. – 2007. – Vol. 13. – P. 35–37.
36. Ladabaum U. Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans / U. Ladabaum, D. Glidden // Neurogastroenterol. Motil. – 2002. – Vol. 14. – P. 395–402.
37. Lin H. C. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome / H. C. Lin // JAMA. – 2004. – Vol. 292, No 7. – P. 852–858.
38. Lombardo L. PPI Use and SIBO: Predisposition or Cause? / L. Lombardo // The American Journal of Gastroenterology. – 2012. – Vol. 107. – P. 1923.
39. Mechanism of gastroprotection by bismuth subsalicylate against chemically-induced oxidative injury in human gastric mucosal cells / D. Bagchi, T. R. McGinn, X. Ye [et al.] // Gastroenterology. – 1998. – Vol. 14. – Р. A62.
40. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia / T. Hiyama, M. Yoshihara, K. Matsuo [et al.] // J. Gastroenterol. Hepatol. – 2007. – Vol. 22, No 3. – P. 304–310.
41. Moon М. А. C. difficile infection, PPI link strengthened. (Clinical report) / М. А. Moon // Family Practice News. – 2010. – Vol. 1. – Р. 40.
42. Neural autoantibody evaluation in functional gastrointestinal disorders : a population-based case-control study / S. J. Pittock, V. A. Lennon, C. L. Dege [et al.] // Digestive Diseases and Sciences. – 2011. – Vol. 56, No 5. – P. 1452–1459.
43. Pharmacological interventions for non-ulcer dyspepsia / P. Moayyedi, S. Soo, J. Deeks [et al.] // Cochrane Database of Syst Rev. – 2003. – Vol. 1. – P. CD001960.
44. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia / K. J. Lee, D. Y. Cha, S. J. Cheon [et al.] // Digestion. – 2009. – Vol. 80, No 1. – P. 58–63.
45. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria / Y. L. Xiao, S. Peng, J. Tao [et al.] // American Journal of Gastroenterology. – 2010. – Vol. 105, No 12. – P. 2626–2631.
46. Probiotics and immunity / A. T. Воrchers, C. Selmi, F. J. Meyers [et al.] // J. Gastroenterol. – 2009. – Vol. 44. – P. 26–46.
47. Proton Pump Inhibitor Therapy Use Does Not Predispose to Small Intestinal Bacterial Overgrowth / S. K. Ratuapli, T. G. Ellington, M. T. O'Neill [еt al.] // The American Journal of Gastroenterology. – 2012. – Vol. 107. – P. 730–735.
48. Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria / Y. C. Hsu, J. M. Liou, S. C. Liao [et al.] // American Journal of Gastroenterology. – 2009. – Vol. 104, No 10. – P. 2534–2542.
49. Rapid gastric emptying, rather than delayed gastric emptying, might provoke functional dyspepsia / M. Kusano, H. Zai, Y. Shimoyama [et al.] // Journal of Gastroenterology and Hepatology. – 2011. – Vol. 26, No 3. – P. 75–78.
50. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection / K. A. Gwee, L. Teng, R. K. M. Wong [et al.] // European Journal of Gastroenterology and Hepatology. – 2009. – Vol. 21, No 4. – P. 417–424.
51. Role of impaired gastric accommodation to a meal in functional dyspepsia / J. Tack, H. Piessevaux, B. Coulie [et al.] // Gastroenterology. – 1998. – Vol. 115, No 6. – P. 1346–1352.
52. Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia / C. Chojnacki, T. Poplawski, G. Klupinska [et al.] // World Journal of Gastroenterology. – 2011. – Vol. 17, No 21. – P. 2646–2651.
53. Sha W. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia / W. Sha, P. J. Pasricha, J. D. Chen // Journal of Clinical Gastroenterology. – 2009. – Vol. 43, No 8. – P. 716–722.
54. Singh V. V. Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment / V. V. Singh, P. P. Toskes // Curr. Treat. Options Gastroenterol. – 2004. – Vol. 7, No 1. – P. 19–28.
55. Small intestinal bacterial overgrowth syndrome / M. Kopacova, J. Bures, J. Cyrany [et al.] // World J. Gastroenterol. – 2010. – Vol. 16, No 24. – P. 2978-2990.
56. Smith J. Bacterial Overgrowth Found in 50% of Those Using PPIs / J. Smith // Family Practice News. – 2010. – Vol. 1. – P. 40.
57. Spiegel B. Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors? / B. Spiegel, W. D. Chey, L. Chang. // Am. J. Gastroenterol. 2008. – Vol. 103, No 2. – P. 2972–2976.
58. Sun H. Bismuth in medicine / H. Sun, L. Zhang, K. Y. Szeto // Met. Ions. Biol. Syst. – 2004. – Vol. 41. – Р. 333–378.
59. Suppression of gastric acid secretion in patients with GERD results in gastric bacterial overgrowth and deconjugation of bile acids / J. Theisen, D. Nehra, D. Citron [et al.] // J. Gastrointest. Surg. – 2000. – Vol. 4. – P. 50–54.
60. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university / H. L. DuPont, P. Sullivan, L. K. Pickering [et al.] // Gastroenterology. – 1977. – Vol. 73. – Р. 715–718.
61. Systematic review : antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia / P. Moayyedi, S. Soo, J. Deeks [et al.] // Aliment. Pharmacol. Ther. – 2003. – Vol. 17. – P. 1215–1227.
62. Talley N. J. Therapeutic options in nonulcer dyspepsia / N. J. Talley // J. Clin. Gastroenterol. – 2001. – Vol. 32. – P. 286–293.
63. Tanum L. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with Mianserin / L. Tanum, U. F. Malt // Am. J. Gastroenterol. – 1998. – Vol. 93. – P. 160–165.
64. Thazhath S. Oral bismuth for chronic intractable diarrheal conditions? / S. Thazhath, M. Haque, T. Florin // Clin. Exp. Gastroenterol. – 2013. – Vol. 6. – Р. 19–25.
65. Treatment of functional gastrointestinal disorders with antidepressant medications : a meta-analysis / J. L. Jackson, P. G. O’Malley, G. Tomkins [et al.] // Am. J. Med. – 2000. – Vol. 108. – P. 65–72.
66. Upper gastrointestinal endoscopy does not reassure patients with functional dyspepsia / L. A. Van Kerkhoven, L. G. Van Rossum, M. G. Van Oijen [et al.] // Endoscopy. – 2006. – Vol. 38. – P. 879–885.
67. Vanderpool C. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases / C. Vanderpool, F. Yan, D. B. Polk // Inflamm. Bowel Dis. – 2008. – Vol. 14. – P. 1585–1596.